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Reviewer #1 (Remarks to the Author): 
221973_1 Study: RNA polymerase II pausing orchestrates gene transcription with splicing 
Bandiera et al. have used ChIP-seq, RNA-seq and 4sU-seq coupled with knockdown (KD) of the long 
noncoding RNA Rn7sk to investigate the role of Rn7sk in keratinocytes differentiation. They have 
noted that the presence of Rn7sk is involved in reprogramming by modulating splicing efficiency. It is 
an important challenge to address the precise mechanisms by which promoter proximal pausing of 
RNA polymerase II (Pol II) influences pre-mature RNA splicing during development. However, the data 
presented in this study do not allow to unambiguously draw conclusions. The methodology of the 
experiments and validation have several major and minor issues, listed in detail below. Unless these 
are addressed comprehensively we cannot recommend this manuscript for publication. 
Major concerns: 
1. The main conclusions regarding altered promoter-proximal pausing cannot be drawn by using 
pausing indices alone. Pol II occupancy (measured here by ChIP) at the 5’ end of genes depends on 
promoter-proximal pausing but it does not directly relate to the kinetics of pausing (Ehrensberger et 
al. Cell 2013, PMID: 23953103). This is because the occupancy signal at a given time depends on the 
number of polymerases and their speed. The use of the pausing index does not allow to draw kinetic 
conclusions i.e. changes of Pol II pause duration, or altered pause release. The reduced Pol II 
occupancy at the 5’ end could be explained equally well by a lower initiation frequency (Ehrensberger 
et al. Cell 2013). A decrease in initiation frequency would result in less RNA output per time. It was 
shown that promoter-proximal pausing and initiation are linked (Shao and Zeitlinger Nature Genet 
2017, PMID: 28504701; Gressel et al. eLife 2017, PMID: 28994650). In addition, the increased signal 
in the gene body as well as around the TTS after Rn7sk KD (e.g. Fig. 2 B and Fig. 3 G-H) could 
indicate slower Pol II speed in the gene body (compared to Ctrl). In summary, using only occupancy 
data the authors cannot conclude how/if pause release rates are changed after KD. This is only 
possible when the transcriptional output per time is considered (Ehrensberger et al. Cell 2013; Gressel 
et al. eLife 2017). The latter is also evident in the data generated by the authors (Fig. 6): while Pol II 
occupancy (measured by ChIP) changes in a similar way for up- and downregulated genes (less 5’ 
occupancy, more gene body/3’ occupancy upon KD), the transcription activity (measured by 4sU-seq) 
differs. How do the authors explain this observation? 
2. How can the authors distinguish effects of promoter-proximal pausing (partially addressed by the 
authors using pausing indices) versus elongation rate (not addressed, requires a measure of 
elongation rate, e.g. 4sUDRB-seq) on splicing? Both processes were shown to modulate splicing 
efficiency: it was shown recently that depletion of the nuclear exon junction complex (EJC) or the 
splicing regulator SRSF2 results in altered promoter-proximal Pol II pausing, and changes in exon 
usage (Akhtar et al. Nature Comm 2019, PMID: 30705266; Ji et al. Cell 2013, ref 13). On the other 
hand, it was shown by several labs that changes in elongation rate lead to alternative splicing (de la 
Mata et al. Mol Cell 2003; Munoz et al. Cell 2009; Close et al. Nature 2012; Dujardin et al. Mol Cell 
2014; Godoy et al. Mol Cell 2019). 
3. It was recently reported that Rn7sk KD inhibits neuronal differentiation (Bazi et al. 2018, PMID: 
29091296). How does this compare to the observation in this study that Rn7sk KD induces 
differentiation? It would be interesting and an important control to compare Rn7sk RNA levels along 
the normal keratinocyte differentiation (Ctrl samples on day 0, 2, 3). In general, the authors should 
briefly summarize in the introduction which observations were made so far using Rn7sk 
overexpression or KD (see also Castelo-Branco et al. Genome Biol 2013, PMID: 24044525). 
Specific comments: 
1. It is a significant challenge to accurately annotate sequences as “active” enhancers. Enhancer 
definitions vary and recent evidence showed that chromatin marks may be misleading in the 
classification of enhancer vs. promoter (Henriques et al. Genes Dev 2018; Dao et al. Nature Genet 
2017; Diao et al. Nature Meth 2017; reviewed in Halfon Trends Genet 2019). Here only H3K4me1 was 
used to classify enhancers (Methods, p. 26). Since H3K27ac data are available, the authors could 
include these to call putative enhancers. In summary, the authors cannot derive enhancer activity 
from chromatin marks, and should refer to these as putative enhancers. 
2. ChIP-seq normalization: it is puzzling that up- and downregulated genes show the same occupancy 
change (see also above, major concern no. 1). This could be due to a normalization artefact. It would 
be recommended to re-analyse the data sets using normalization on “unchanged” genes as described 
e.g. by Mahat et al. Mol Cell 2016, PMID: 27052732. 
3. It is unclear how the size factor was calculated for PlaB samples. The description in the Methods 
sections sounds like DESeq2 normalization. However, to track changes in splicing the authors should 
calculate size factors only on the exons (-t exon), and apply the resulting size factor to normalize the 
intron levels. Subsequently DE analysis can be performed. 
4. Abstract, line 4-5: transcriptional bursting can be influenced by many regulatory steps of 
transcription (see e.g. Nicolas et al. 2017, PMID 28573295). Furthermore, to describe bursting, 
several parameters (i.e. burst duration, size and frequency) are critical. Thus, we wonder if there is 
sufficient evidence that pausing is a key step in the regulation of bursting? Specifically, what 
parameters may be controlled by pausing (compared to the initiation frequency)? 
5. Introduction, line 12-15: biochemical evidence (Vos et al. 2018, PMID: 30135580 and 30135578; 
summarized in Adelman 2018, PMID: 30143755) shows that the paused elongation complex adopts a 
nonproductive conformation of the RNA-DNA hybrid which is stabilized by DSIF (Spt5) and NELF. 
Thus, the adoption of the paused state is not due to negative regulation of P-TEFb. The release of the 
paused elongation complex requires that P-TEFb (Cdk9) is present (1st point of regulation by P-TEFb 
recruitment/delivery, cite here e.g. Baboric et al. 2001, PMID: 11545735; Rahl et al. 2010, PMID: 
20434984; Takahashi et al. 2011, PMID: 21729782) and active (2nd point of regulation by the 
inactive 7SK snRNP complex). This is not always clearly stated throughout the text. Please rephrase 
esp. the abstract and discussion accordingly. 
6. Introduction, line 12-15: note, that it is an open question in the field (due to lack of specific 
antibodies) if P-TEFb (Cdk9) phosphorylates serine 2. It was also shown to phosphorylate serine 5 as 
well as the Pol II linker to the CTD (Vos et al. 2018, PMID: 30135578). Please reword accordingly. 
7. What does “presence of RNA Pol II pause release” mean? Promoter-proximal pause durations vary 
between genes, as well as between conditions - even if the pause release factors are present. 
8. Experimental set-up and analysis. 
- Biological replicates: it is unclear if biological or technical replicates were performed for ChIP-seq, 
RNA-seq and 4sU-seq experiments. Please clarify this. At least two biological replicates should be 
performed per condition. 
- qPCR and RNA-seq data normalization: (i) did the authors test if GAPDH (RT-qPCR) is not affected by 
changes in Rn7sk (since pausing is a genome-wide phenomenon)? In general, it would be good if at 
least two housekeeping genes are compared, or synthetic spike-ins are added which allow for 
unbiased normalization. (ii) The use of spike-ins is also critical for the RNA-seq and 4sU-seq, 
especially when global transcription factors are manipulated (Loven et al. Cell 2012, PMID: 
23101621). 
- ChIP-seq data: it is not clear if replicates were merged for the analysis, and for metagene plots how 
many genes were analysed (Fig. 2 B, 3 G-H). Please add this information to the figure legend. In Fig. 
4 I-J it is unclear why only one out of four replicates is shown. How does the metagene analysis look 
for merged replicates? In general, it would be good if confidence intervals could be added to the 
average signal of the metagene plots to interpret Ctrl vs. KD. 
- “Data not shown” (p. 5, 6): for transparency this statement should be avoided. If data are not 
provided the respective statements should be removed. Since the transgenic mouse lines are key to 
the findings of the paper, viability data should be added to the Supplementary Information (the 
authors claim that both did not show “any gross phenotype”). 
- Why are Rn7sk KD times different for each experimental set-up? It would be useful for the reader to 
add a supplementary table providing an overview of all the conditions used in this study. 
- Reference genome: why are the authors using the hg19 annotation for the RNA-seq and ChIP-seq 
data sets (the updated annotation hg38 is available since 2013, and lifting older data sets for 
comparison is fast via http://genome.ucsc.edu/cgi-bin/hgLiftOver), but use hg38 for ATAC-seq and 
the GC content calculation? 
- Results: did the authors control if Larp7 is also depleted on the protein level upon knock-down? If 
yes, please add the respective Western blot to Fig. S2C. 
- Results (p. 9, line 14-16; Fig. S4 C-D): the rescue experiment is a critical control. The statement 
that repression of cell cycle regulators was prevented appears to be not significant for Cdk1. Please 
rephrase the sentence accordingly, and test significance as done in A-B. 
9. Missing information. 
- Several figures are missing information which statistical test was used and which p-value 
corresponds to asterisk(s) to the figure legend. Please add the missing information e.g. for Figures S1, 
S4, S5, S6. 
- Methods, all -seq experiments: add information how many cycles were sequenced, and if single or 
paired-end mode was used. 
- Several figures are missing information how many genes are depicted in the metagene profiles 
(n=?). E.g. Fig. 2 B: please add the number of protein-coding genes (n=?) depicted in the metagene 
plot. The same issues for figures 3, 4, 6. 
- Fig. 2 H-J: it is confusing that the FC (H), ? (I), or log2 FC (J) are shown. Please add the missing title 
of the y-axis in (I). 
- Fig. S4 A: which siRNA was used? 
- Fig. 5 B: please add genomic coordinates and information which genome browser was used. 
- Methods: were duplicates removed for RNA-seq and 4sU-seq? Please add this information to the 
methods. 
- Fig. S4 B: please add which cell line was used to compare the 3 siRNAs. 
10. Missing references. 
- Introduction, line 2-4: please add Gariglio et al. 1981, PMID: 6269056 - they were the first 
describing the accumulation of Pol II at the beta-globin locus. 
- Introduction, line 5 and 12: please add Core and Adelman 2019, PMID: 31123063 - it’s the most 
recent review on promoter-proximal events. 
- Introduction, line 17-19: please add Shao and Zeitlinger Nature Genet 2017, PMID: 28504701 and 
Gressel et al. 2017, PMID: 28994650 - they were the first describing that pausing can also limit 
initiation, and thus, regulate transcriptional activity. 
- Methods, p. 21, line 5: add reference for “as previously described”. 
- Discussion, p. 15, line 5: the impact of promoter-proximal pausing on bursts was shown by 
Ehrensberger et al. Cell 2013 as well as Shao and Zeitlinger Nature Genet 2017. Please add these. 
11. Other comments. 
- Spelling: results, line 18: “ChIP” 
- Fig. 1 + 3: what statistical test is referred to by “multiple t-test”? 
Reviewer #2 (Remarks to the Author): 
Bandiera et al. address the important question how pausing of RNA polymerase II (Pol II), a key 
regulatory step in RNA synthesis, affects gene expression and adult tissue homeostasis. The authors 
present several remarkable observations that will largely advance our current understanding how RNA 
synthesis regulation is mechanistically tied to cellular differentiation. 
Most interestingly, the observation that the forced release of transcription by depleting the noncoding 
RNA Rn7sk results in repressed RNA levels is unexpected and could be convincingly linked to splicing 
defects and co-transcriptional RNA degradation. Further, it is demonstrated that Rn7sk, a crucial 
component of the ribonucleoprotein complex coordinating Pol II pausing, is specifically required for the 
correct expression of a distinct set of genes that are marked by highly accessible promoters, lower 
guanosine/cytosine content, shorter introns and weaker 3’ splice sites. In particular, the Rn7sk 
depletion results in repression of cell cycle regulators and promotes cellular differentiation. Although 
the data are exciting, novel and appear robust as the authors explore two experimental systems: 
genetic manipulation of mouse epidermis in vivo and human primary keratinocytes in vitro, some 
critical points need to be addressed. 
1. The authors demonstrate that Rn7sk depletion leads to reduced expression of integrin alpha 6 
(figure 2 H). In this context it needs to be investigated if some of the observed phenotypes, including 
colony forming potential, epidermal reconstitution (ex vivo assay on de-epidermalised dermis) as well 
as the differentiation and changes in cellularity seen in Rn7sk cKO mice is a direct result of integrin 
regulation (rather than a specific response to Pol II pausing). 
2. The direct functional link between cell cycle gene regulation and induction of terminal differentiation 
in Rn7sk-depleted keratinocytes needs to be further clarified. Are cell cycle regulation and 
differentiation independently controlled by Rn7sk activity? Can the authors exclude that cellular stress 
response mechanisms lead to the phenotype, e.g. change in cellularity in vivo and in vitro? 
3. The recovery of the phenotype and wound-like response, despite complete absence of Rn7sk seen 
in vivo is interesting. However, it needs to be shown that recovery of the epidermis indeed occurs in 
Rn7sk-depleted tissue. 
Reviewer #3 (Remarks to the Author): 
This paper describes the effect of knocking out the 7SK RNA gene in transgenic mice epidermis (by 
keratinocyte selective KO) or depleting 7SK RNA by siRNA in an epidermal cell line, which normally 
acts to restrict Pol II elongation by sequestering P-TEFb. In both systems a clear cell growth defect is 
detected which in the cell line study is attributed to a cell cycle defect. Thus, 7SK depletion causes a 
selective down regulation in the expression of genes involved in cell cycle progression. Overall, I felt 
that the data presented in Fig 1-3 looks reliable and convincing (as far as this non-expert reviewer in 
epidermis differentiation is concerned). The data presented in Fig 3 clearly shows that while as 
expected 7SK depletion reduces TSS associated Pol II pausing, surprisingly many genes are down 
regulated in expression. To seek an explanation for this apparent data contradiction, initially 
chromatin analysis was tested to see if these cell cycle associated genes displayed repressed 
chromatin features. However as shown in Fig 4 apparently 7SK depletion has no significant detectible 
effects on chromatin structure over relevant promoters or enhancers. Again, I found these data very 
credible. 
Specific concerns: 
1) Figure 5 shows by isolating pulse labelled nascent RNA (4SU) that 7SK depletion does reduce 
nascent transcription levels. I think these data would benefit from more gene screen shots clearly 
showing this reduction in nascent transcription. The TP63 gene data is hard to appreciate (Fig 5B). 
Really it would be good to have back up data using GRO-seq or mNET-seq here. 
2) I have serious misgivings about some of transcriptomic analysis related to splicing aimed at 
understanding the mechanism behind the 7SK kd phenotypes. Principally I think 4SU labelling is 
problematic for looking at splicing as it is possible that this analogue incorporation into RNA may 
impair splicing which relies on splice site base pairing to snRNAs. Really these data need repeating 
using other nascent transcription analysis methods that will give unbiased splicing efficiency 
measures. Possibly a comparison of chromatin vs nucleoplasm RNA looking for intron retention (+/-
7SK depletion). Alternatively, mNET-seq using the splicing specific Pol II CTD S5P selection would be a 
good approach (see Nojima et al. Mol Cell 72,369 2018). 
3) I am unsure if the bioinfomatic correlation of low GC content and weaker 3’ splice sites for 7SK 
depletion repressed genes is a very meaningful correlation. 
4) I don’t understand why PlaB treatment which will clearly block all splicing has an antagonistic effect 
on 7SK depletion induced splicing defects. Surely the combination of 7SK depletion followed by PlaB 
treatment should cause additive effects on splicing inhibition, not rescue effects? Is this again related 
to potential problems with using 4SU labelling to study splicing efficiency. Gene specific screen shots 
are needed here to present these data in a more convincing manner. 
Overall, I feel that while the first parts of this paper look compelling and interesting I don’t consider 
the splicing connection is convincingly made. More work is needed as suggested above to either 
confirm or rule out a splicing connection. 
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221973_1 Study: RNA polymerase II pausing orchestrates gene transcription with splicing 
Bandiera et al. have used ChIP-seq, RNA-seq and 4sU-seq coupled with knockdown (KD) of 
the long noncoding RNA Rn7sk to investigate the role of Rn7sk in keratinocytes differentiation. 
They have noted that the presence of Rn7sk is involved in reprogramming by modulating 
splicing efficiency. It is an important challenge to address the precise mechanisms by which 
promoter proximal pausing of RNA polymerase II (Pol II) influences pre-mature RNA splicing 
during development. However, the data presented in this study do not allow to unambiguously 
draw conclusions. The methodology of the experiments and validation have several major and 
minor issues, listed in detail below. Unless these are addressed comprehensively we cannot 
recommend this manuscript for publication. 
We thank the referees for the in-depths review of our manuscript and the constructive 
criticism helping us to improve our manuscript. We have now extensively re-analysed 
our data and provide novel mechanistic insights how Rn7sk directly regulates gene-
specific transcription initiation (see detailed responses to major concerns below).  
 
Major concerns: 
1. The main conclusions regarding altered promoter-proximal pausing cannot be drawn by 
using pausing indices alone. Pol II occupancy (measured here by ChIP) at the 5’ end of genes 
depends on promoter-proximal pausing but it does not directly relate to the kinetics of pausing 
(Ehrensberger et al. Cell 2013, PMID: 23953103). This is because the occupancy signal at a 
given time depends on the number of polymerases and their speed. The use of the pausing index 
does not allow to draw kinetic conclusions i.e. changes of Pol II pause duration, or altered 
pause release. The reduced Pol II occupancy at the 5’ end could be explained equally well by 
a lower initiation frequency (Ehrensberger et al. Cell 2013). A decrease in initiation frequency 
would result in less RNA output per time. It was shown that promoter-proximal pausing and 
initiation are linked (Shao and Zeitlinger Nature Genet 2017, PMID: 28504701; Gressel et al. 
eLife 2017, PMID: 28994650). In addition, the increased signal in the gene body as well as 
around the TTS after Rn7sk KD (e.g. Fig. 2 B and Fig. 3 G-H) could indicate slower Pol II 
speed in the gene body (compared to Ctrl). In summary, using only occupancy data the authors 
cannot conclude how/if pause release rates are changed after KD. This is only possible when 
the transcriptional output per time is considered (Ehrensberger et al. Cell 2013; Gressel et al. 
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eLife 2017). The latter is also evident in the data generated by the authors (Fig. 6): while Pol 
II occupancy (measured by ChIP) changes in a similar way for up- and downregulated genes 
(less 5’ occupancy, more gene body/3’ occupancy upon KD), the transcription activity 
(measured by 4sU-seq) differs. How do the authors explain this observation? 
We agree with the referee that our conclusion that repression of Rn7sk altered promoter-
proximal pausing cannot be drawn from pausing indices alone. Therefore, we also 
quantified Pol II phosphorylation changes at serine 2 and 5 by Western blotting (Figure 
3C). We find the same level of serine 5 phosphorylation, indicating that transcription 
initiation is unchanged upon depletion of Rn7sk. A two-fold increase in serine 2 
phosphorylation indicated enhanced productive elongation. Reduced levels of Pol II 
occupancy cannot explain these results because the overall Pol II levels are unchanged 
(Figure 3C).   
A lower Pol II initiation frequency should increase the pausing duration (Gressel et al., 
2019; Gressel et al., 2017; Shao and Zeitlinger, 2017). We consistently find reduced 
pausing indices in Rn7sk-depleted cells (Figure 3B; Figure S3C, D).  
In addition, lower initiation frequencies without pausing are likely to cause closed or 
repressive chromatin architectures (Core and Adelman, 2019). However, we find no 
evidence for changes in chromatin architecture in Rn7sk-depleted cells (Figure 5A-J; 
Figure S5A, B). Therefore, we disagree with the referee that lower occupancy of Pol II 
alone could explain our findings.  
We agree with the referee that an increased signal in the gene body as well as around the 
TTS after Rn7sk knockdown could indicate slower Pol II speed in the gene body. 
However, we do not find evidence for significant slower global elongation (Figure 3A). 
We would also expect to see a reduction of serine 2 phosphorylation, which was not the 
case (Figure 3C).  
In summary, we entirely agree with the referees that it is challenging to explain our data 
with the current knowledge that 7SK ribonucleoprotein complex sequesters P-TEFb. 
Please note, that previous studies identified an inhibitory role on P-TEFb in response to 
ultraviolet radiation, yet a recent study also finds little changes in global transcription 
upon Rn7sk-depletion in the absence of stress (Nguyen et al., 2001; Studniarek et al., 
2021; Yang et al., 2001).  
As requested by the referees, we now provide further analyses demonstrating a functional 
role of the 7SK snRNP complex in transcription initiation specifically of highly 
transcribed bi-directional gene pairs. We have now also re-written our manuscript to 
better highlight the novel functional roles of Rn7sk instead of focusing entirely on Pol II 
pausing.   
 
2. How can the authors distinguish effects of promoter-proximal pausing (partially addressed 
by the authors using pausing indices) versus elongation rate (not addressed, requires a 
measure of elongation rate, e.g. 4sUDRB-seq) on splicing? Both processes were shown to 
modulate splicing efficiency: it was shown recently that depletion of the nuclear exon junction 
complex (EJC) or the splicing regulator SRSF2 results in altered promoter-proximal Pol II 
pausing, and changes in exon usage (Akhtar et al. Nature Comm 2019, PMID: 30705266; Ji 
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et al. Cell 2013, ref 13). On the other hand, it was shown by several labs that changes in 
elongation rate lead to alternative splicing (de la Mata et al. Mol Cell 2003; Munoz et al. Cell 
2009; Close et al. Nature 2012; Dujardin et al. Mol Cell 2014; Godoy et al. Mol Cell 2019). 
The referee is correct, both promoter proximal pausing and changes in transcription 
elongation rate could contribute to our findings. 7SK has been described to also prevent 
transcription downstream of polyadenylation sites at several active genes (Castelo-
Branco et al., 2013), and we detected a significant enrichment of sense genes downstream 
of Rn7sk-dependent genes (Figure 4C). However, because this effect was less 
pronounced we focused on the role of Rn7sk in bidirectional transcription.  
 
3. It was recently reported that Rn7sk KD inhibits neuronal differentiation (Bazi et al. 2018, 
PMID: 29091296). How does this compare to the observation in this study that Rn7sk KD 
induces differentiation? It would be interesting and an important control to compare Rn7sk 
RNA levels along the normal keratinocyte differentiation (Ctrl samples on day 0, 2, 3). In 
general, the authors should briefly summarize in the introduction which observations were 
made so far using Rn7sk overexpression or KD (see also Castelo-Branco et al. Genome Biol 
2013, PMID: 24044525). 
Bazi and colleagues depleted 7SK during an embryonic stem cell differentiation assay 
towards neurons. The read-out for reduced differentiation was reduction of the neural 
differentiation markers Map2 and Nestin (Bazi et al., 2018). The reason for lower 
expression of the markers in the cultured cells was not investigated. Thus, a reduction of 
proliferation at the neural progenitor stage may have contributed to their finding.  
We show in Figure 2E that RNA expression levels of Rn7sk does not significantly change 
during epidermal differentiation (Ctr siRNA).  




1. It is a significant challenge to accurately annotate sequences as “active” enhancers. 
Enhancer definitions vary and recent evidence showed that chromatin marks may be 
misleading in the classification of enhancer vs. promoter (Henriques et al. Genes Dev 2018; 
Dao et al. Nature Genet 2017; Diao et al. Nature Meth 2017; reviewed in Halfon Trends Genet 
2019). Here only H3K4me1 was used to classify enhancers (Methods, p. 26). Since H3K27ac 
data are available, the authors could include these to call putative enhancers. In summary, the 
authors cannot derive enhancer activity from chromatin marks, and should refer to these as 
putative enhancers. 
Cell type-specific enhancers were defined as H3K4me1 peaks, which did not overlap a 
promoter region (from -900 bp to +100 bp of the annotated transcriptional start site) of 
an Ensembl transcript (see Methods). At these sites, we find no differences in H3K4me1 
or H3K27ac peaks (Figure 5I, J). As requested by the referee, we now refer to these sites 
as putative enhancers (not as active enhancers) in the text.  
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Our initial expectation from the literature was to find a small set of enhancers that 
changed in the absence of 7SK (Flynn et al., 2016). Therefore, we first considered peaks 
with H3K4me1 or/and H3K27Ac to identify poised enhancers (Creyghton et al., 2010). 
Since we did not find differences in either, we defined them by both H3K27ac and 
H3K4me1 marks (Figure 5E-J; Figure S5A, B).  
 
2. ChIP-seq normalization: it is puzzling that up- and downregulated genes show the same 
occupancy change (see also above, major concern no. 1). This could be due to a normalization 
artefact. It would be recommended to re-analyse the data sets using normalization on 
“unchanged” genes as described e.g. by Mahat et al. Mol Cell 2016, PMID: 27052732. 
As requested by the referee, we re-analysed our data using common ‘unchanged’ genes 
in all datasets (n=199) and confirm a significant genome-wide reduction in RNA Pol II 
occupancy at the TSS but not at the gene body (Figure 3A).  
To address the referees’ concern how the same Pol II occupancy change can have 
opposite effects on RNA synthesis, we closer inspected the common features of the up- 
and down-regulated nascent transcripts in Rn7sk-depeleted cells. We now show that the 
top up-regulated nascent RNAs often contained several alternative transcriptional start 
sites (Figure 3I; upper panel; Figure S3H, J). This could have an additive effect and lead 
to an accumulation of transcript reads over the gene body, even though Pol II occupancy 
at individual start sites is lower.  
The top down-regulated genes were commonly bi-directionally transcribed (Figure 3I; 
lower panel; Figure 3K, lower panel; Figure S3H, J). Simultaneous transcriptional 
initiation on opposite strands is likely to require more complex regulatory processes. We 
now show that Rn7sk is indeed specifically required for efficient bi-directional 
transcription of highly expressed gene pairs (Figure 4; Figure S4). Since this finding is 
novel and explains the gene-specific effects on cell cycle genes for instance, we have 
now focused on the function of Rn7sk in bi-directional transcription and changed the text 
and title accordingly.  
 
3. It is unclear how the size factor was calculated for PlaB samples. The description in the 
Methods sections sounds like DESeq2 normalization. However, to track changes in splicing 
the authors should calculate size factors only on the exons (-t exon), and apply the resulting 
size factor to normalize the intron levels. Subsequently DE analysis can be performed. 
We agree with the referee and performed the normalization as the referee describes it 
whenever possible. We only used a slightly modified approach for some of the PlaB 
analyses due to the global changes in overall mRNA levels following PlaB treatment. We 
have now excluded the PlaB experiment and therefore no longer needed the alternative 
approach. The manuscript has been updated with the following sentence “Raw intron and 
exon read counts were normalized using DESeq2-derived size factors based only on the exonic 
counts.” to clarify how normalization was done.    
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4. Abstract, line 4-5: transcriptional bursting can be influenced by many regulatory steps of 
transcription (see e.g. Nicolas et al. 2017, PMID 28573295). Furthermore, to describe 
bursting, several parameters (i.e. burst duration, size and frequency) are critical. Thus, we 
wonder if there is sufficient evidence that pausing is a key step in the regulation of bursting? 
Specifically, what parameters may be controlled by pausing (compared to the initiation 
frequency)? 
We agree with the referee and have omitted the sentence from the abstract.  
 
5. Introduction, line 12-15: biochemical evidence (Vos et al. 2018, PMID: 30135580 and 
30135578; summarized in Adelman 2018, PMID: 30143755) shows that the paused elongation 
complex adopts a nonproductive conformation of the RNA-DNA hybrid which is stabilized by 
DSIF (Spt5) and NELF. Thus, the adoption of the paused state is not due to negative regulation 
of P-TEFb. The release of the paused elongation complex requires that P-TEFb (Cdk9) is 
present (1st point of regulation by P-TEFb recruitment/delivery, cite here e.g. Baboric et al. 
2001, PMID: 11545735; Rahl et al. 2010, PMID: 20434984; Takahashi et al. 2011, PMID: 
21729782) and active (2nd point of regulation by the inactive 7SK snRNP complex). This is 
not always clearly stated throughout the text. Please rephrase esp. the abstract and discussion 
accordingly. 
As requested by the referee, we have re-worded the introduction and included the 
citations.  
 
6. Introduction, line 12-15: note, that it is an open question in the field (due to lack of specific 
antibodies) if P-TEFb (Cdk9) phosphorylates serine 2. It was also shown to phosphorylate 
serine 5 as well as the Pol II linker to the CTD (Vos et al. 2018, PMID: 30135578). Please 
reword accordingly. 
As requested by the referee, we have re-worded the introduction and included the 
citations.  
 
7. What does “presence of RNA Pol II pause release” mean? Promoter-proximal pause 
durations vary between genes, as well as between conditions - even if the pause release factors 
are present. 
The phrase has now been omitted from the text.  
 
8. Experimental set-up and analysis. 
- Biological replicates: it is unclear if biological or technical replicates were performed for 
ChIP-seq, RNA-seq and 4sU-seq experiments. Please clarify this. At least two biological 
replicates should be performed per condition. 
This information is now provided in the respective figure legends.  
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- qPCR and RNA-seq data normalization: (i) did the authors test if GAPDH (RT-qPCR) is not 
affected by changes in Rn7sk (since pausing is a genome-wide phenomenon)? In general, it 
would be good if at least two housekeeping genes are compared, or synthetic spike-ins are 
added which allow for unbiased normalization. (ii) The use of spike-ins is also critical for the 
RNA-seq and 4sU-seq, especially when global transcription factors are manipulated (Loven et 
al. Cell 2012, PMID: 23101621). 
The RNA levels of GAPDH were not significantly down-regulated in of the dataset 
(Figure S4G). We also performed RTqPCRs using 18S rRNA as a standard. This 
information is now included in the Methods section.  
 
In Fig. 4 I-J it is unclear why only one out of four replicates is shown. How does the metagene 
analysis look for merged replicates? In general, it would be good if confidence intervals could 
be added to the average signal of the metagene plots to interpret Ctrl vs. KD. 
All four replicates are now provided in Figure S5A, B. 
 
- “Data not shown” (p. 5, 6): for transparency this statement should be avoided. If data are 
not provided the respective statements should be removed. Since the transgenic mouse lines 
are key to the findings of the paper, viability data should be added to the Supplementary 
Information (the authors claim that both did not show “any gross phenotype”). 
The data regarding the mouse viability is provided in Figure S1J. The phrase “data not 
shown” has been removed.  
 
- Why are Rn7sk KD times different for each experimental set-up? It would be useful for the 
reader to add a supplementary table providing an overview of all the conditions used in this 
study. 
To only study direct functions of Rn7s, we aimed to analyse the cells as soon as possible 
after Rn7s-knockdown. The requested information in now provided in Supplementary 
Table S3. 
 
- Reference genome: why are the authors using the hg19 annotation for the RNA-seq and ChIP-
seq data sets (the updated annotation hg38 is available since 2013, and lifting older data sets 
for comparison is fast via http://genome.ucsc.edu/cgi-), but use hg38 for ATAC-seq and the GC 
content calculation? 
This project has been started several years ago and therefore, the analyses have been done 
using hg19. Only one set of data analysis (ATAC-seq) was performed using hg38. Since 
there are no major differences in the annotation of protein coding genes between the two 
versions, we now provide all analyses in hg19.  
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- Results: did the authors control if Larp7 is also depleted on the protein level upon knock-
down? If yes, please add the respective Western blot to Fig. S2C. 
Since the Larp7 knockdown experiments served as an additional control to test for Rn7sk-
specific knockdown effects, we have only measured RNA levels at the time. Since we do 
confirm repression of Rn7sk and cell cycle regulators in the absence of Larp7 (Figure 
S4F; lower panel), we can assume that the reduction of RNA levels lead to reduced 
translation.  
 
- Results (p. 9, line 14-16; Fig. S4 C-D): the rescue experiment is a critical control. The 
statement that repression of cell cycle regulators was prevented appears to be not significant 
for Cdk1. Please rephrase the sentence accordingly, and test significance as done in A-B. 
We entirely agree with the referee and provided significance when applicable to all of 
our data. The rescue experiments in primary epidermal cells is highly challenging 
because these are not immortalized lines, they easily differentiate and thereby naturally 
repress cell cycle regulators. To address the referees’ concern, we have now provided 
additional rescue experiments in an immortalized epidermal line (Figure 7F, G; Figure 
S7H). We confirm the cell cycle regulators to be directly affected by depletion of Rn7sk 
and can demonstrate that also the cell cycle alterations were directly caused by Rn7sk 
(Figure 7F, G).   
 
9. Missing information. 
- Several figures are missing information which statistical test was used and which p-value 
corresponds to asterisk(s) to the figure legend. Please add the missing information e.g. for 
Figures S1, S4, S5, S6. 
All details are now provided in the source data file.  
 
- Methods, all -seq experiments: add information how many cycles were sequenced, and if 
single or paired-end mode was used. 
This information is available at GEO 
(http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE101217) 
 
- Several figures are missing information how many genes are depicted in the metagene profiles 
(n=?). E.g. Fig. 2 B: please add the number of protein-coding genes (n=?) depicted in the 
metagene plot. The same issues for figures 3, 4, 6. 
The number of genes has now been included throughout the figures.  
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- Fig. 2 H-J: it is confusing that the FC (H), ? (I), or log2 FC (J) are shown. Please add the 
missing title of the y-axis in (I). 
To be consistent, we changed all graphs to log2-fold change and the missing title is 
now included.  
 
- Fig. S4 A: which siRNA was used? 
If not otherwise stated all experiments were done using siRNA5. This information is 
given in the text (line 117-118).  
 
- Fig. 5 B: please add genomic coordinates and information which genome browser was used. 
All genome browser shots were generated using the UCSC Genome Browser 
(https://genome-euro.ucsc.edu).  
 
- Methods: were duplicates removed for RNA-seq and 4sU-seq? Please add this information to 
the methods. 
Duplicates are commonly not removed from RNA-seq data, and we also did not do so.  
 
- Fig. S4 B: please add which cell line was used to compare the 3 siRNAs. 
Please note that the numbering of the primary keratinocyte cultures is arbitrary 
(alphabetical) to denote different donors. We used one line throughout the study and state 
in the text when we validated the experiments in different independent lines from other 
donors.  
 
10. Missing references. 
- Introduction, line 2-4: please add Gariglio et al. 1981, PMID: 6269056 - they were the first 
describing the accumulation of Pol II at the beta-globin locus. 
- Introduction, line 5 and 12: please add Core and Adelman 2019, PMID: 31123063 - it’s the 
most recent review on promoter-proximal events. 
- Introduction, line 17-19: please add Shao and Zeitlinger Nature Genet 2017, PMID: 
28504701 and Gressel et al. 2017, PMID: 28994650 - they were the first describing that 
pausing can also limit initiation, and thus, regulate transcriptional activity. 
- Methods, p. 21, line 5: add reference for “as previously described”. 
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- Discussion, p. 15, line 5: the impact of promoter-proximal pausing on bursts was shown by 
Ehrensberger et al. Cell 2013 as well as Shao and Zeitlinger Nature Genet 2017. Please add 
these. 
As requested, we have included the missing citation if relevant after editing the text.  
 
11. Other comments. 
- Spelling: results, line 18: “ChIP” 
The spelling mistake has been corrected.  
- Fig. 1 + 3: what statistical test is referred to by “multiple t-test”? 





Bandiera et al. address the important question how pausing of RNA polymerase II (Pol II), a 
key regulatory step in RNA synthesis, affects gene expression and adult tissue homeostasis. The 
authors present several remarkable observations that will largely advance our current 
understanding how RNA synthesis regulation is mechanistically tied to cellular differentiation. 
Most interestingly, the observation that the forced release of transcription by depleting the 
noncoding RNA Rn7sk results in repressed RNA levels is unexpected and could be convincingly 
linked to splicing defects and co-transcriptional RNA degradation. Further, it is demonstrated 
that Rn7sk, a crucial component of the ribonucleoprotein complex coordinating Pol II pausing, 
is specifically required for the correct expression of a distinct set of genes that are marked by 
highly accessible promoters, lower guanosine/cytosine content, shorter introns and weaker 3’ 
splice sites. In particular, the Rn7sk depletion results in repression of cell cycle regulators and 
promotes cellular differentiation. Although the data are exciting, novel and appear robust as 
the authors explore two experimental systems: genetic manipulation of mouse epidermis in vivo 
and human primary keratinocytes in vitro, some critical points need to be addressed. 
We thank the referee for finding our data novel, robust, and exciting. As requested by the 
referee, we have now provided more evidence that Rn7sk directly regulates cell cycle 
genes leading to enhanced differentiation as a secondary effect in vitro and in vivo (see 
detailed response to the specific comments below).  
  
1. The authors demonstrate that Rn7sk depletion leads to reduced expression of integrin 
alpha 6 (figure 2 H). In this context it needs to be investigated if some of the observed 
phenotypes, including colony forming potential, epidermal reconstitution (ex vivo assay on de-
epidermalised dermis) as well as the differentiation and changes in cellularity seen in Rn7sk 
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cKO mice is a direct result of integrin regulation (rather than a specific response to Pol II 
pausing). 
We agree with the referee that the down-regulation of ITGA6 might 
contribute to the cellular phenotype of Rn7sk-depletion in the in vitro 
and in vivo assays at later time points (i.e. longer than 48 hours) and 
in calcium-high conditions. However, all our mechanistic analyses in 
Figures 3 to 7, in which we identify the cell cycle regulators as 
underlying driver of the phenotype, were performed between 12 to 
24 hours. At these early time points and without a differentiation 
stimulus, we do not measure down-regulation of ITGA6 in the 4SU 
or total RNA sequencing datasets (see figure panel on the right). 
 
2. The direct functional link between cell cycle gene regulation and induction of terminal 
differentiation in Rn7sk-depleted keratinocytes needs to be further clarified. Are cell cycle 
regulation and differentiation independently controlled by Rn7sk activity? Can the authors 
exclude that cellular stress response mechanisms lead to the phenotype, e.g. change in 
cellularity in vivo and in vitro? 
We now demonstrate that cell cycle regulators but not up-regulated differentiation 
markers significantly change in expression as early as 12 hours after Rn7sk knock-down 
(Figure S4C, D). Moreover, expression of cell cycle regulators and the effect on cell 
cycle can be rescued by re-expressing Rn7sk in knock-down cells (Figure S4H, I; Figure 
7F, G). Thus, the referee is correct, cell cycle regulation and epidermal differentiation 
are independently controlled, and enhanced differentiation is highly likely a secondary 
effect of cell cycle regulator repression and hence Rn7sk knock-down. 
Whether cellular stress responses contribute to the observed phenotype is an interesting 
question. Although we do not find genes regulating the cellular stress response to be 
significantly changed in our analyses (Figure 7A, B), we cannot fully exclude that the 
stress response contributed to the phenotype. We now show that DNA repair genes are 
often bi-directionally transcribed and are also enriched in Rn7sk-depleted cells (Figure 
4H,I). Thus, a mis-regulated DNA damage and repair response might indeed contribute 
to the phenotype.   
 
3. The recovery of the phenotype and wound-like response, despite complete absence of 
Rn7sk seen in vivo is interesting. However, it needs to be shown that recovery of the epidermis 
indeed occurs in Rn7sk-depleted tissue. 
We provide histological sections labelling Rn7sk RNA in the epidermis more than 30 
days after the last treatment in Figure S1I (upper panels) and in the total knockout mice 







This paper describes the effect of knocking out the 7SK RNA gene in transgenic mice epidermis 
(by keratinocyte selective KO) or depleting 7SK RNA by siRNA in an epidermal cell line, which 
normally acts to restrict Pol II elongation by sequestering P-TEFb. In both systems a clear cell 
growth defect is detected which in the cell line study is attributed to a cell cycle defect. Thus, 
7SK depletion causes a selective down regulation in the expression of genes involved in cell 
cycle progression. Overall, I felt that the data presented in Fig 1-3 looks reliable and 
convincing (as far as this non-expert reviewer in epidermis differentiation is concerned). The 
data presented in Fig 3 clearly shows that while as expected 7SK depletion reduces TSS 
associated Pol II pausing, surprisingly many genes are down regulated in expression. To seek 
an explanation for this apparent data contradiction, initially chromatin analysis was tested to 
see if these cell cycle associated genes displayed repressed chromatin features. However as 
shown in Fig 4 apparently 7SK depletion has no significant detectible effects on chromatin 
structure over relevant promoters or enhancers. Again, I found these data very credible. 
We thank the referee for finding our discovery that 7SK regulates epidermal 
differentiation reliable and convincing. As described below in detail, the main concern 
of this referee is using 4SU RNA sequencing data in splicing analyses. We agree with 
the referee’s concern and omitted the splicing analyses using the 4SU datasets from the 
study. Instead, we have now using total RNA sequencing datasets to determine the 
splicing differences.   
 
1) Figure 5 shows by isolating pulse labelled nascent RNA (4SU) that 7SK depletion does 
reduce nascent transcription levels. I think these data would benefit from more gene screen 
shots clearly showing this reduction in nascent transcription. The TP63 gene data is hard to 
appreciate (Fig 5B). Really it would be good to have back up data using GRO-seq or mNET-
seq here. 
As requested by the referee, we have now included more genome browser shots 
throughout our manuscript to better highlight the differences in nascent RNA production.  
We also agree that mNET-seq would be the ideal method to further validate our data. We 
have spent a year in trying to establish the method according to the published protocols. 
Unfortunately, the antibodies used in the original protocol are no longer available, and 
we failed to get the method to work using alternative antibodies. We believe that GRO-
seq would not give us more information as it follows the same principle than the 4SU-
seq approach.  
To accommodate the referee’s comments, we have now re-analysed our current data sets 
in far greater detail and provide further data to substantiate our claims.  
 
2) I have serious misgivings about some of transcriptomic analysis related to splicing aimed 
at understanding the mechanism behind the 7SK kd phenotypes. Principally I think 4SU 
labelling is problematic for looking at splicing as it is possible that this analogue incorporation 
into RNA may impair splicing which relies on splice site base pairing to snRNAs. Really these 
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data need repeating using other nascent transcription analysis methods that will give unbiased 
splicing efficiency measures. Possibly a comparison of chromatin vs nucleoplasm RNA looking 
for intron retention (+/-7SK depletion). Alternatively, mNET-seq using the splicing specific Pol 
II CTD S5P selection would be a good approach (see Nojima et al. Mol Cell 72,369 2018). 
The referee raises a very good point. Although 4SU-labelled RNA has been used to study 
splicing effects before (Windhager et al., 2012), we agree that the 4SU-labelled RNA 
should probably not be used to identify splicing differences. Therefore, we omitted these 
analyses from the manuscript and now perform the splicing analyses only on total RNA-
seq datasets.  
We now also focus on the main function of 7SK on transcription initiation and provide 
more and novel mechanistic insights on how Rn7sk is required is to orchestrate bi-
directional transcription. Moreover, we identify the cell cycle regulators as direct targets 
of Rn7sk-mediated transcriptional initiation.  
 
3) I am unsure if the bioinfomatic correlation of low GC content and weaker 3’ splice sites for 
7SK depletion repressed genes is a very meaningful correlation. 
We agree with the referee and have now omitted the panels from the revised version of 
this manuscript.  
 
4) I don’t understand why PlaB treatment which will clearly block all splicing has an 
antagonistic effect on 7SK depletion induced splicing defects. Surely the combination of 7SK 
depletion followed by PlaB treatment should cause additive effects on splicing inhibition, not 
rescue effects? Is this again related to potential problems with using 4SU labelling to study 
splicing efficiency. Gene specific screen shots are needed here to present these data in a more 
convincing manner. 
The referee is correct, PlaB treatment did indeed have an additive effect on splicing. It 
did however rescue Rn7sk-sensitive gene transcription because the targets were not 
degraded.  
However, because the referee is correct in voicing concern over the use of 4SU data in 
splicing analyses (see also comment 2), we have re-analyzed our data using only the total 
RNA-seq data sets.  
We do believe that splicing is affected in the Rn7sk-depleted cells, but deeper analyses 
into impaired transcription in the absence of Rn7sk now provided us with a novel 
mechanism explaining the cellular phenotype observed in vitro and in vivo. Therefore, 
we how focus our study on bi-directional transcription.  
 
Overall, I feel that while the first parts of this paper look compelling and interesting I don’t 
consider the splicing connection is convincingly made. More work is needed as suggested 
above to either confirm or rule out a splicing connection. 
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We agree with the referee and now provide extensive and new analyses explaining the 
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REVIEWERS' COMMENTS 
Reviewer #2 (Remarks to the Author): 
The authors conducted new experiments and modified the text to address the critical points I raised in 
its first version. 
However, I have one final comment about the manuscript: The authors generated two different 
transgenic mouse lines carrying floxed Rn7sk alleles (plus and minus PSE). It becomes not clear 
whether the in vivo studies were performed with both mouse lines or which line was involved 
performing a particular set of experiments. This should be stated in the figure legends and 
material/methods part of the manuscript. 
Reviewer #3 (Remarks to the Author): 
This extensively revised paper describes the effect of either a knock out or siRNA mediated depletion 
of 7sk snRNA, initially in skin epidermis differentiation. In the first part of the paper it is shown that 
skin epidermal division is perturbed by loss of 7sk resulting in a reduction in cellularity. The rest of the 
paper seeks to understand this epidermal phenotype by looking at the effect of 7sk depletion on gene 
expression (especially transcription and associated RNA processing). 
7sk is well known to negatively regulate the key transcription elongation kinase Cdk9 as part of the 
cyclin T associated protein pTEFb. This regulation is achieved by 7sk sequestration into an inactive 
complex. The effect of 7sk loss might therefore have been expected to activate many genes. However, 
a class of genes was shown here to be inhibited by loss of 7sk. These inhibited genes functionally 
correlate with often divergently transcribed genes that are associated with cell cycle and chromosome 
organisation. This may account for the effect of 7sk depletion on epidermal cellularity. 
Overall, I feel that this revised paper addresses my previous concerns (especially overclaiming effects 
on splicing). However, one is still left without a very clear mechanistic understanding of 7sk function in 
cellular differentiation. Rather the data presented raises interesting questions for further experimental 
work that is beyond the scope of this study.













The authors conducted new experiments and modified the text to address the critical points I 
raised in its first version.  
 
However, I have one final comment about the manuscript: The authors generated two different 
transgenic mouse lines carrying floxed Rn7sk alleles (plus and minus PSE). It becomes not 
clear whether the in vivo studies were performed with both mouse lines or which line was 
involved performing a particular set of experiments. This should be stated in the figure legends 
and material/methods part of the manuscript. 
 
Both transgenic lines were analysed and displayed the same phenotype. Most data in 
Figure 1 and Supplementary Figure 1 were obtained from line 1 (see Figure 1a). 
Exceptions were Figure 1e and f, which contain the pooled data from both lines. This 





This extensively revised paper describes the effect of either a knock out or siRNA mediated 
depletion of 7sk snRNA, initially in skin epidermis differentiation. In the first part of the paper 
it is shown that skin epidermal division is perturbed by loss of 7sk resulting in a reduction in 
cellularity. The rest of the paper seeks to understand this epidermal phenotype by looking at 
the effect of 7sk depletion on gene expression (especially transcription and associated RNA 
processing).  
 
7sk is well known to negatively regulate the key transcription elongation kinase Cdk9 as part 
of the cyclin T associated protein pTEFb. This regulation is achieved by 7sk sequestration into 
an inactive complex. The effect of 7sk loss might therefore have been expected to activate many 
genes. However, a class of genes was shown here to be inhibited by loss of 7sk. These inhibited 
genes functionally correlate with often divergently transcribed genes that are associated with 
cell cycle and chromosome organisation. This may account for the effect of 7sk depletion on 
epidermal cellularity. 
 
Overall, I feel that this revised paper addresses my previous concerns (especially overclaiming 
effects on splicing). However, one is still left without a very clear mechanistic understanding 
of 7sk function in cellular differentiation. Rather the data presented raises interesting questions 
for further experimental work that is beyond the scope of this study. 
 
We thank the referee for finding our manuscript now suitable for publication.  
